MORI-MEMORIAL-FOUNDATION
8.12.2020 07:02:13 CET | Business Wire | Press release
London, New York, Tokyo, Paris and Singapore once again emerged as the world’s most comprehensively attractive cities, in that order, in the Global Power City Index (GPCI) 2020 report. This report is published by The Mori Memorial Foundation’s Institute for Urban Strategies , a research body established by Mori Building , a leading urban developer in Tokyo. Although the composition of the top five cities has remained unchanged since 2016, London and New York have shown a marked uptrend over that time while the scores of Tokyo and Paris have slipped, and Singapore has closed in on Paris. Among the other cities in the top 10, Berlin extended its scores in the area of Livability, leapfrogging Seoul into seventh place overall. Shanghai improved its ratings in all areas aside from Research and Development, greatly improving its overall position from #30 to #10 and overtaking Sydney to enter the top 10 for the first time.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201207005386/en/
Since 2008, the annual GPCI report has ranked 40 or more major cities in terms of their “magnetism,” or their overall power to attract creative individuals and enterprises from around the world. Cities are rated on the basis of 70 indicators in six functions: Economy, R&D, Cultural Interaction, Livability, Environment, and Accessibility. In an effort to reflect changes in the conditions affecting global cities, the GPCI continuously fine-tunes its indicators and data-collection methods.
In 2020, the most serious event was the spread of the novel coronavirus (COVID-19), labeled by the WHO in March as a global pandemic. COVID-19 subsequently had a wide-ranging impact on cities' economic networks and lifestyles as a result of the accompanying lockdowns, travel prohibitions and other restrictions on people’s movements. In the GPCI 2020 survey, conducted in August this year, the influence of the COVID-19 pandemic was reflected in a number of indicators, including “Workstyle Flexibility” and “Satisfaction with Urban Cleanliness”. With the accompanying transition to online working, internet speed was added as a factor to “Variety of Workplace Options”. On top of these changes, new indicators such as “Air Quality”, “Number of Flight Arrivals and Departures” and “Ease of Mobility by Taxi or Bicycle” were added. Moreover, based on a separate survey of urban lifestyle changes, some factors emerged which might be added as new criteria in the GPCI evaluation process.
Highlights (Cities from #1-10)
- London (#1), maintaining its #1 position for the ninth consecutive year, was placed in the top 10 of all categories aside from Environment. It achieved a remarkable improvement in Accessibility where it took first place, replacing Paris, while maintaining its comprehensive lead in the area of Cultural Interaction. On the other hand, its score in the Economy field fell for the second year running following a drop in its “GDP Growth Rate”. It will become even more important for London to maintain its overwhelming strength in Cultural Interaction if there is economic fallout as a result of COVID-19, which continues to affect people’s movements and interaction.
- New York (#2) was once again dominant in the Economy category this year, with improved scores in “Total Employment” and “Employees in Business Support Services”; it also secured the highest ratings in “Variety of Workplace Options”. Though the city maintained its top ranking in Research & Development and Cultural Interaction, its scores in “Workstyle Flexibility” fell, causing it to drop in the Livability rankings, the city’s weakest area. Given the impact of COVID-19 and the political divisions in the United States, Livability is a key area where the city should seek improvements.
- Tokyo (#3) continued to display consistent strengths in all areas while also raising its score in the area of Environment and Accessibility. Despite Japan’s capital retaining third place in the Economy field, the gap between it and next-placed Singapore narrowed. Livability was the only area where the city's rankings fell, due to a drop in scores for “Workstyle Flexibility”. The city has improved its position in Cultural Interaction since it was selected as an Olympic host city in 2013, yet it still has a potential for improvement in “Nightlife Options” and “Number of Luxury Hotel Rooms.”
- Paris (#4) fell back somewhat, in a reversal of its improved ratings last year. Although the city boosted its score in the Economy category as a result of improved scores in “Corporate Tax Rates”, it fell from first place in the areas of Livability and Accessibility. Its ranking in the area of Environment also fell due to low scores in “Satisfaction with Urban Cleanliness”, possibly as a result of the strike action by city sanitation workers in February 2020.
- Singapore (#5) reaffirmed its credentials as a stable city, achieving improved rankings in all areas except Cultural Interaction. The city state, a global business hub, raised its scores in the Economy field and closed the gap in this area on third-placed Tokyo. It overtook Hong Kong to claim first position in “Economic Freedom” and also improved its score in “Variety of Workplace Options” (#3). Competition with other Asian financial centers such as Tokyo and Hong Kong is expected to intensify.
- Amsterdam (#6) achieved first place in the area of Livability, replacing Paris, due largely to an improvement in its “Total Unemployment Rate” scores. The city was also rated highest overall in terms of “Ease of Mobility by Taxi or Bicycle” and took second place overall in Accessibility. However, its score in the Environment category dropped sharply due to low ratings in “Satisfaction with Urban Cleanliness”.
- Berlin (#7) overtook Seoul in the overall rankings, achieving significantly improved Livability scores, particularly in “Workstyle Flexibility” and with improved “Commitment to Climate Action” ratings helping to boost its performance in the Environment field. However, its rankings in “Variety of Workplace Options” fell and its weak position in Economy (#29) was unchanged from last year.
- Seoul (#8) greatly improved its ranking in Environment with strong ratings in “Waste Recycle Rate” (#2) and significant improvement in “Comfortable Temperature Levels”. In the Livability category, the city scored worst in “Workstyle Flexibility”, dropping from #34 to #39 position. It maintained its strong position in Research & Development, scoring in the top 10 in five out of eight indicators.
- Hong Kong (#9) saw improved ratings in the Economy area with very high scores in “Variety of Workplace Options” (#2) and “Economic Freedom”. It also raised its score in Research & Development due to improvements in “Number of Researchers” and “Number of Patents”. On the other hand, its ranking in the Cultural Interaction field fell from #13 to #20 due to a drop in scores for “Tourist Attractions” and “Attractiveness of Shopping Options”.
- Shanghai (#10) made the biggest jump in overall ratings in 2020, from #30 to #10. The main reason for this was its dramatic improvement in “Variety of Workplace Options”(#16) in the Economy area, as well as “Workstyle Flexibility” in Livability, where the city scored the highest in the wake of the COVID-19 pandemic. Experiencing the impact of COVID-19 earlier than many other cities, Shanghai took the opportunity to accelerate the development new ways of working.
The full press release of Mori Memorial Foundation’s GPCI 2020 Report can be viewed at the following link:
http://www.mori-m-foundation.or.jp/pdf/GPCI2020_release_en.pdf
(in English)
View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005386/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
